Grown Rogue International (GRUSF) Share-based Compensation (IS) (2011 - 2019)
Grown Rogue International's (GRUSF) quarterly Share-based Compensation (IS) came in at $112080.0 in Q2 2019, down 28.24% quarter-over-quarter from $156197.3 in Q3 2018.
Grown Rogue International (GRUSF) Share-based Compensation (IS) (2011 - 2019) Analysis & Trends
Grown Rogue International's Share-based Compensation (IS) history runs 8 years deep, the most recent figure standing at $112080.0 for Q2 2019.
- On a quarterly basis, Share-based Compensation (IS) changed N/A year-over-year to $112080.0 in Q2 2019; TTM through Apr 2019 was $112080.0, a N/A change from a year earlier, with the FY2018 full-year figure at $156197.3, down 87.23% from the prior year.
- Share-based Compensation (IS) retreated to $112080.0 in Q2 2019 per GRUSF's latest filing, from $156197.3 in the prior quarter.
- Across five years, Share-based Compensation (IS) topped out at $1.3 million in Q3 2017 and bottomed at $66217.4 in Q3 2015.
- The 5-year median for Share-based Compensation (IS) is $102967.5 (2017), against an average of $243806.3.
- Across the five-year window, Share-based Compensation (IS) jumped 616.96% in 2016 and plunged 87.54% in 2018, its largest moves.
- Year by year, Share-based Compensation (IS) stood at $66217.4 in 2015, then jumped by 55.4% to $102900.8 in 2016, then surged by 1118.27% to $1.3 million in 2017, then plunged by 87.54% to $156197.3 in 2018, then dropped by 28.24% to $112080.0 in 2019.
- Per Business Quant, the three latest GRUSF Share-based Compensation (IS) figures stand at $112080.0 (Q2 2019), $156197.3 (Q3 2018), and $106182.8 (Q2 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.32 Mn | 85.61 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2019 | 112,080.00 |
| Apr 30, 2019 | 112,080.00 |
| Aug 31, 2018 | 156,197.29 |
| Aug 31, 2018 | 156,197.29 |
| May 31, 2018 | 106,182.78 |
| May 31, 2018 | 106,182.78 |
| Feb 28, 2018 | 81,170.87 |
| Feb 28, 2018 | 81,170.87 |
| Aug 31, 2017 | 1.25 Mn |
| Aug 31, 2017 | 1.25 Mn |
| May 31, 2017 | 101,214.35 |
| May 31, 2017 | 101,214.35 |
| Feb 28, 2017 | 102,967.52 |
| Feb 28, 2017 | 102,967.52 |
| Nov 30, 2016 | 102,900.79 |
| Nov 30, 2016 | 102,900.79 |
| Aug 31, 2016 | 474,751.91 |
| Aug 31, 2016 | 474,751.91 |
| May 31, 2016 | 473,363.01 |
| May 31, 2016 | 473,363.01 |